Phosphotransfer reactions in the failing heart

Translational Cardiology: Molecular Basis of Cardiac Metabolism, Cardiac Remodeling, Translational Therapies and Imaging Techniques

Volumn , Issue , 2012, Pages 39-62

  Ingwall, Joanne S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHO-TRANSFER;

EID: 84875176480     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-61779-891-7_2     Document Type: Chapter

References (82)

1. Ingwall JS. ATP and the heart. Boston, MA: Kluwer; 2002.
2. Dzeja P, Terzic A. Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci. 2009;10(4):1729-72.
3. Dzeja PP, Chung S, Terzic A. Integration of adenylate kinase, glycolytic and glycogenolytic circuits in cellular energetics. In: Saks V, editor. Molecular system bioenergetics: energy for life. Weinheim: Wiley-VCH; 2007.
4. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356(11):1140-51.
5. Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta Mol Cell Res. 2011;1813:1360-72.
6. Guzun R, Timohhina N, Tepp K, et al. Systems bioenergetics of creatine kinase networks: physiological roles of creatine and phosphocreatine in regulation of cardiac cell function. Amino Acids. 2011;40(5):1333-48.
7. Schlattner U, Tokarska-Schlattner M, Ramirez S, et al. Mitochondrial kinases and their molecular interaction with cardiolipin. Biochim Biophys Acta. 2009;1788(10):2032-47.
8. Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 2011;40(5):1271-96.
9. Lipmann F. Metabolic generation and utilization of phosphate bond energy. Adv Enzymol. 1941;1:99-162.
10. Krebs H, Kornberg H. Energy transformations in living matter. Berlin: Springer; 1957.
11. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31 P NMR magnetization transfer study. J Biol Chem. 1985;260(6):3512-7.
12. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem. 1985;54:831-62.
13. Bessman SP, Fonyo A. The possible role of the mitochondrial bound creatine kinase in regulation of mitochondrial respiration. Biochem Biophys Res Commun. 1966;22(5):597-602.
14. Turner DC, Wallimann T, Eppenberger HM. A protein that binds speci fi cally to the M-line of skeletal muscle is identi fi ed as the muscle form of creatine kinase. Proc Natl Acad Sci USA. 1973;70(3):702-5.
15. Savabi F, Geiger PJ, Bessman SP. Myo fi brillar end of the creatine phosphate energy shuttle. Am J Physiol. 1984;247(5 Pt 1):C424-32.
16. Jacobus WE, Lehninger AL. Creatine kinase of rat heart mitochondria. Coupling of creatine phosphorylation to electron transport. J Biol Chem. 1973;248(13):4803-10.
17. Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res. 2001;89(2):153-9.
18. Saks VA. Creatine kinase isoenzymes and the control of cardiac contraction. In: Jacobus WE, Ingwall JS, editors. Heart creatine kinase. Baltimore, MD: Williams and Wilkins; 1980. p. 109-24.
19. Wallimann T, Dolder M, Schlattner U, et al. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors. 1998;8(3-4):229-34.
20. Dzeja PP, Zeleznikar RJ, Goldberg ND. Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J Biol Chem. 1996;271(22):12847-51.
21. Zeleznikar RJ, Dzeja PP, Goldberg ND. Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle. J Biol Chem. 1995;270(13):7311-9.
22. Ingwall JS, Shen W. On energy circuits in the failing myocardium. Eur J Heart Fail. 2011;12(12):1268-70.
23. Ellington WR. Evolution and physiological roles of phosphagen systems. Annu Rev Physiol. 2001;63:289-325.
24. Sekrecka-Belniak A, Balcerzak M, Buchet R, Pikula S. Active creatine kinase is present in matrix vesicles isolated from femurs of chicken embryo: implications for bone mineralization. Biochem Biophys Res Commun. 2011;391(3):1432-6.
25. Ebermann L, Piper C, Kuhl U, et al. Impact of myocardial in fl ammation on cytosolic and mitochondrial creatine kinase activity and expression. Basic Res Cardiol. 2009;104(3):247-57.
26. Streijger F, Pluk H, Oerlemans F, et al. Mice lacking brain-type creatine kinase activity show defective thermoregulation. Physiol Behav. 2009;97(1):76-86.
27. Dorsten FA, Wyss M, Wallimann T, Nicolay K. Activation of sea-urchin sperm motility is accompanied by an increase in the creatine kinase exchange fl ux. Biochem J. 1997;325 (Pt 2):411-6.
28. van Horssen R, Janssen E, Peters W, et al. Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. J Biol Chem. 2009;284(3):1620-7.
29. Yang YC, Fann MJ, Chang WH, Tai LH, Jiang JH, Kao LS. Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. J Biol Chem. 2010;285(36):28275-85.
30. Saupe KW, Spindler M, Hopkins JCA, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. J Biol Chem. 2000;275(26):19742-6.
31. Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem. 2003;278(20):17760-6.
32. Spindler M, Meyer K, Stromer H, et al. Creatine kinase-de fi cient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis. Am J Physiol Heart Circ Physiol. 2004;287(3):H1039-45.
33. Ashish G, Ashwin A, Yibin W, Michelle K.L, V.P. Chacko, D. Brian F, Viviane C, Sa S, Jonathan A.K, Jason S, Shenghan L, Nazareno P, Charles S, Gerstenblith G, and Robert G. Weiss Creatine. Kinase-mediated improvement of function in failing mouse heartsprovides causal evidence the failingheart is energy starved. J Clin Invest. 2012;122(1):291-302.
34. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res. 1996;78(5):893-902.
35. Gupta A, Chacko VP, Schar M, Akki A, Weiss RG. Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging. 2011;4(1):42-50.
36. Perry SB, McAuliffe J, Balschi JA, Hickey PR, Ingwall JS. Velocity of the creatine kinase reaction in the neonatal rabbit heart: role of mitochondrial creatine kinase. Biochemistry. 1988;27(6):2165-72.
37. Osbakken M, Douglas PS, Ivanics T, Zhang DN, Van Winkle T. Creatine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertensioninduced cardiac hypertrophy. J Am Coll Cardiol. 1992;19(1):223-8.
38. Weiss RG, Gerstenblith G, Bottomley PA. ATP fl ux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci USA. 2005;102(3):808-13.
39. Johnson JE, Wold BJ, Hauschka SD. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol. 1989;9(8):3393-9.
40. Van Dorsten FA, Nederhoff MG, Nicolay K, Van Echteld CJ. 31P NMR studies of creatine kinase fl ux in M-creatine kinase-de fi cient mouse heart. Am J Physiol. 1998;275(4 Pt 2):H1191-9.
41. Ventura-Clapier R, Kuznetsov AV, d'Albis A, van Deursen J, Wieringa B, Veksler VI. Muscle creatine kinase-de fi cient mice. I. Alterations in myo fi brillar function. J Biol Chem. 1995;270(34):19914-20.
42. Veksler VI, Kuznetsov AV, Anflous K, et al. Muscle creatine kinase-de fi cient mice. II. Cardiac and skeletal muscles exhibit tissue-speci fi c adaptation of the mitochondrial function. J Biol Chem. 1995;270(34):19921-9.
43. Ingwall JS. On the hypothesis that the failing heart is energy starved: Lessons learned from the metabolism of ATP and creatine. Curr Hypertens Rep. 2006;8(6):457-64.
44. Boehm E, Chan S, Monfared M, Wallimann T, Clarke K, Neubauer S. Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine. Am J Physiol Endocrinol Metab. 2003;284(2):E399-406.
45. Neubauer S, Remkes H, Spindler M, et al. Down regulation of the Na(+)-creatine co-transporter in failing human myocardium and in experimental heart failure. Circulation. 1999;100: 1847-50.
46. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S. Biochemical and clinical characteristics of creatine de fi ciency syndromes. Acta Biochim Pol. 2004;51(4):875-82.
47. Strutz-Seebohm N, Shojaiefard M, Christie D, Tavare J, Seebohm G, Lang F. PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8. Cell Physiol Biochem. 2007;20(6):729-34.
48. Tian R, Ingwall JS. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol. 1996;270(4 Pt 2):H1207-16.
49. Ingwall J. Energetic basis for heart failure. In: Mann D, editor. Heart failure: a companion to Braunwald's heart disease. 2nd ed. St Louis, MO: Elsevier; 2011. p. 103-18.
50. Janssen E, Dzeja PP, Oerlemans F, et al. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J. 2000;19(23):6371-81.
51. Lutz S, Mura RA, Hippe HJ, Tiefenbacher C, Niroomand F. Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling. Br J Pharmacol. 2003;140(6):1019-26.
52. Annesley SJ, Bago R, Mehta A, Fisher PR. A genetic interaction between NDPK and AMPK in Dictyostelium discoideum that affects motility, growth and development. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(4-5):341-9.
53. Ventura-Clapier R, Kaasik A, Veksler V. Structural and functional adaptations of striated muscles to CK de fi ciency. Mol Cell Biochem. 2004;256-257(1-2):29-41.
54. Crozatier B, Badoual T, Boehm E, et al. Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-de fi cient mice. FASEB J. 2002;16(7):653-60.
55. Boehm E, Ventura-Clapier R, Mateo P, Lechene P, Veksler V. Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fi bres of mice de fi cient in mitochondrial and cytosolic creatine kinase. J Mol Cell Cardiol. 2000;32(6):891-902.
56. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-speci fi c isoenzymes of creatine kinase. Circ Res. 1998;82(8):898-907.
57. Aliev MK, van Dorsten FA, Nederhoff MG, et al. Mathematical model of compartmentalized energy transfer: its use for analysis and interpretation of 31P-NMR studies of isolated heart of creatine kinase de fi cient mice. Mol Cell Biochem. 1998;184(1-2):209-29.
58. Abraham MR, Selivanov VA, Hodgson DM, et al. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem. 2002;277(27):24427-34.
59. Carrasco AJ, Dzeja PP, Alekseev AE, et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci USA. 2001;98(13):7623-8.
60. Pucar D, Janssen E, Dzeja PP, et al. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J Biol Chem. 2000;275(52):41424-9.
61. Pucar D, Bast P, Gumina RJ, et al. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2002;283(2):H776-82.
62. Herrmann G, Decherd M. The chemical nature of heart failure. Ann Intern Med. 1939;12: 1233-44.
63. Pool PE, Spann Jr JF, Buccino RA, Sonnenblick EH, Braunwald E. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. Circ Res. 1967;21(3):365-73.
64. Ingwall JS. The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Hear J. 1984;5(Suppl F):129-39.
65. Ingwall JS, Kramer MF, Fifer MA, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313(17):1050-4.
66. Ingwall JS, Weiss RG. Is the failing heart energy starved? Circ Res. 2004;95(2):135-45.
67. Nascimben L, Ingwall JS, Pauletto P, et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94(8):1894-901.
68. Jung WI, Sieverding L, Breuer J, et al. 31 P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 1998;97(25):2536-42.
69. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96(7):2190-6.
70. Shen W, Asai K, Uechi M, et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation. 1999;100:2113-8.
71. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28(4):755-65.
72. Shen W, Vatner DE, Vatner SF, Ingwall JS. Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha. J Mol Cell Cardiol. 2010;48(4):591-9.
73. Wu F, Zhang J, Beard DA. Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism. Proc Natl Acad Sci USA. 2009; 106(17):7143-8.
74. Neill WA, Ingwall JS. Stabilization of a derangement in adenosine triphosphate metabolism during sustained, partial ischemia in the dog heart. J Am Coll Cardiol. 1986;8(4):894-900.
75. Matsuzaki M, Gallagher KP, Kemper WS, White F, Ross JJ. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation. 1983;68(1):170-82.
76. Wallis J, Lygate CA, Fischer A, et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporteroverexpressing transgenic mice. Circulation. 2005;112(20):3131-9.
77. ten Hove M, Lygate CA, Fischer A, et al. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-de fi cient guanidinoacetate-N-methyltransferase- knockout mice. Circulation. 2005;111(19):2477-85.
78. Park SJ, Zhang J, Ye Y, et al. Myocardial creatine kinase expression after left ventricular assist device support. J Am Coll Cardiol. 2002;39(11):1773-9.
79. Shen W, Spindler M, Higgins M, et al. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. J Mol Cell Cardiol. 2005;39(3):537-44.
80. Lutz S, Hippe HJ, Niroomand F, Wieland T. Nucleoside diphosphate kinase-mediated activation of heterotrimeric G proteins. Methods Enzymol. 2004;390:403-18.
81. Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC, Terzic A. Adenylate kinase-catalyzed phosphotransfer in the myocardium: increased contribution in heart failure. Circ Res. 1999; 84(10):1137-43.
82. Aksentijevic D, Lygate C, Makinen K, et al. High-energy phosphotransfer in the failing mouse heart-role of adenylate kinase and glycolytic enzymes. Eur J Heart Fail. 2011;12:1282-9.